Glenmark Pharmaceuticals consolidated net profit rises 22.84% in the December 2022 quarter

Sales rise 7.98% to Rs 3392.24 crore

Net profit of Glenmark Pharmaceuticals rose 22.84% to Rs 272.58 crore in the quarter ended December 2022 as against Rs 221.90 crore during the previous quarter ended December 2021. Sales rose 7.98% to Rs 3392.24 crore in the quarter ended December 2022 as against Rs 3141.47 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales3392.243141.47 8 OPM %18.2822.06 -PBDT599.39640.35 -6 PBT437.12521.42 -16 NP272.58221.90 23

Powered by Capital Market - Live News